CStone Pharmaceuticals is a biopharma company devoted to the development and commercialization of innovative immuno-oncology therapies and molecularly targeted drugs. The company's vision is to become globally recognized as a leading Chinese biopharma company by bringing innovative and differentiated oncology therapies to cancer patients in China and worldwide.
CStone has successfully built up a world-class management team, with clinical development and translational medicine as its core competence. Combining with significant financial funding and rich oncology pipeline, CStone is uniquely positioned as the partner of choice for multi-national pharmaceutical / biotech companies to develop drugs in China and the Asia Pacific region.
Currently, CStone is seeking strategic partners in the following areas: